Market Overview

UPDATE: Morgan Stanley Upgrades Walgreen to Equal-weight; Express Overhang Removed

Share:
Related WAG
IPO Outlook: API-Focused Software Tech Company Apigee Is A Silent Growth Story
Jana Partners' Barry Rosenstein: 'The Walgreens Situation Is Terrific'

Morgan Stanley raised its rating on Walgreen (NYSE: WAG) from Overweight to Equalweight and removed its previous price target of $31.

Morgan Stanley noted, "The Express Scripts dispute is over, but focus now turns to growth prospects for Alliance Boots and related Europe risk. We still see an unsettled US EPS backdrop (couponing to win back Express customers, weak front-end and new Express-Medco contract margins)."

Walgreen closed at $35.52 on Thursday.

Latest Ratings for WAG

DateFirmActionFromTo
Dec 2014BarclaysMaintainsEqual-weight
Dec 2014JP MorganMaintainsOverweight
Dec 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Upgrades Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (WAG)

Around the Web, We're Loving...